2025-05-16 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided.

## NTRA Stock Analysis

**Ticker:** NTRA
**Company Name:** Natera Inc.
**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing for reproductive health, oncology, and organ health.

### 1. Performance vs. S&P 500 (VOO)

*   **NTRA Cumulative Return:** 125.73%
*   **VOO Cumulative Return:** 77.09%
*   **Absolute Spread:** 48.6 (NTRA outperforms VOO by 48.6%)
*   **Relative Spread:** 13.1 (NTRA's outperformance is at the 13.1th percentile of its historical range.)
    *Interpretation:* NTRA has significantly outperformed the S&P 500 over the specified period. However, the relative spread suggests that the current outperformance is relatively low compared to its historical extremes.

**Alpha, Beta Analysis Table:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | -6.0%  | 62.4% | -32.0% | -0.1 | 1.2    |
| 2016-2018  | 29.0%  | 80.1% | 14.0%  | 0.2  | 1.9    |
| 2017-2019  | 159.0% | 80.1% | 133.0% | 0.9  | 4.6    |
| 2018-2020  | 530.0% | 80.1% | 506.0% | 0.4  | 13.6   |
| 2019-2021  | 356.0% | 62.9% | 303.0% | 0.2  | 12.8   |
| 2020-2022  | -119.0% | 62.9% | -124.0% | 0.2  | 5.5    |
| 2021-2023  | -482.0% | 69.9% | -498.0% | 1.1  | 8.6    |
| 2022-2024  | -75.0%  | 70.5% | -91.0%  | 1.2  | 21.6   |
| 2023-2025  | 74.0%  | 72.8% | 46.0%  | 0.8  | 20.4   |

*   **CAGR (Compound Annual Growth Rate):**  Shows significant volatility over different periods, with very high growth in some periods (e.g., 2018-2020) and substantial losses in others (e.g., 2021-2023).
*   **MDD (Maximum Drawdown):** Consistently high MDD indicates significant risk and potential for large losses.
*   **Alpha:** Demonstrates periods of significant outperformance (positive alpha) and underperformance (negative alpha) relative to the benchmark.
*   **Beta:** Fluctuates, suggesting varying degrees of correlation with the market.  Higher betas in recent periods (e.g., 2022-2024) indicate increased market sensitivity.
*   **Cap(B):** Market capitalization has varied.

### 2. Recent Price Action

*   **Current Price:** 149.375
*   **Last Market Data:**
    *   Price: 149.401
    *   Previous Close: 151.34
    *   Change: -1.28
*   **Moving Averages:**
    *   5-day MA: 156.257
    *   20-day MA: 152.7332
    *   60-day MA: 149.9241

*Analysis:* The current price is below the 5-day and 20-day moving averages, suggesting a short-term downtrend. The price is also slightly below the 60-day moving average, indicating a potential weakening of the longer-term trend. The negative change in the last market data confirms a recent price decrease.

### 3. Technical Indicators

*   **MRI (Market Risk Indicator):** 0.35 (Low Risk)
    *Interpretation:* The MRI suggests a low-risk environment, which may be misleading considering the volatility of the stock and the high MDD values.
*   **RSI (Relative Strength Index):** 50.78
    *Interpretation:*  An RSI around 50 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO (Percentage Price Oscillator):** -0.0688
    *Interpretation:* A negative PPO suggests that the short-term moving average is below the long-term moving average, which can indicate a downtrend.
*   **Delta_Previous_Relative_Divergence:** -2.7 (Short-term decrease)
    *Interpretation:* Indicates a decrease in relative outperformance compared to the benchmark, suggesting weakening momentum.
*   **Recent Price Change:** {'price': 149.401, 'previousClose': 151.34, 'change': -1.28}
    *Interpretation:* The recent negative price change of -1.28 could signal a short-term downward trend or volatility, potentially influenced by the news and events mentioned below.
*   **Expected Return:** 166.9%
    *Interpretation:* A very high expected return suggests significant potential upside if held for the long term (2+ years) compared to the S&P 500. This should be viewed cautiously, as it's based on historical data and may not reflect future performance.

### 4. Recent News & Significant Events

*   **2025-05-14:** Business developments, regulatory changes, or market events.
*   **2025-05-13:** Analyst discussions on performance and outlook.
*   **2025-05-12:** Notable stock volatility.
*   **2025-05-16:** Market experts highlight risks and opportunities.

*Interpretation:* The news suggests that Natera is experiencing volatility and is subject to analyst scrutiny. Investors should carefully monitor these events for further developments.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-09 | -0.5  | 0.50 B$   |
| 2024-11-12 | -0.26 | 0.44 B$   |
| 2024-08-09 | -0.3  | 0.41 B$   |
| 2024-05-10 | -0.56 | 0.37 B$   |
| 2025-05-09 | -0.56 | 0.37 B$   |

*Analysis:* Natera has consistently reported negative EPS (Earnings Per Share), indicating a lack of profitability. While revenue has generally been increasing, the continued losses are a concern.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |
| 2024-03-31 | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | $1.24B  | -5.40%  |
| 2024-12-31 | $1.20B  | -4.50%  |
| 2024-09-30 | $0.88B  | -3.60%  |
| 2024-06-30 | $0.84B  | -4.48%  |
| 2024-03-31 | $0.79B  | -8.51%  |

*Analysis:* Revenue has been increasing consistently, and profit margins are relatively high, indicating good operational efficiency. However, the negative ROE (Return on Equity) reflects the company's inability to generate profits from its equity.  Equity has also been increasing.

### 7. Summary and Conclusion

Natera Inc. (NTRA) has shown strong revenue growth and significant historical outperformance compared to the S&P 500. However, the company faces several challenges:

*   **Lack of Profitability:** Consistent negative EPS and ROE are a major concern.
*   **High Volatility:** The high MDD and recent price fluctuations indicate a risky investment.
*   **Short-Term Downtrend:** Recent price action and technical indicators suggest a potential short-term downtrend.
*   **Mixed Signals:** The MRI indicates low risk, but other factors suggest otherwise.

**Overall:** NTRA presents a mixed picture.  While the long-term expected return is high, the company's lack of profitability and volatile nature make it a high-risk investment. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing in NTRA.  Monitoring upcoming news, earnings reports, and analyst opinions will be crucial.
